RSS   Newsletter   Contact   Advertise with us
Post Online Media

Diurnal Group appoints Richard Bungay as CFO

Diurnal GroupDiurnal Group, a specialty pharmaceutical company, announces the appointment of Richard Bungay as chief financial officer effective January 16, 2017.

Mr. Bungay has over 20 years' experience in corporate roles within R&D-based companies within the biotechnology and pharmaceutical sector, including as CFO of both public and private companies, with a particular focus on financing, investor relations and business development.

Most recently, Mr. Bungay has been CFO and Chief Operating Officer of Mereo BioPharma Group, a biopharmaceutical company focused on rare and specialty diseases.

Earlier in his career, Mr. Bungay was Director of Corporate Communications and Strategic Planning at Celltech Group plc until its acquisition by UCB.

Following his time at Celltech, Mr. Bungay was CEO and before that CFO of Chroma Therapeutics.


 LATEST MOVES FROM United Kingdom 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy